Furthermore, these data showed that uL3 autoregulates its expression [33,34] and uL3 status is highly identified in cellular responses to specific anticancer agents in p53 mutant lung and p53 deletion colon cancer cells. Here, RPL3 is linked to malignant colon neoplasm.